tenofovir has been researched along with adenosine monophosphate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Du, J; Furman, PA; Mosley, RT; Murakami, E; Sofia, MJ | 1 |
| El Amri, C; Kaci, M; Lefort, V; Mathé, C; Périgaud, C; Uttaro, JP | 1 |
| Antoniou, T; Park-Wyllie, LY; Tseng, AL | 1 |
| Duan, Y; Zhou, C; Zhu, HL | 1 |
| Eades, W; Shen, Y; Yan, B | 1 |
| Byakika-Kibwika, P; D'Avolio, A; Kaboggoza, JP; Lamorde, M; Waitt, C; Walimbwa, SI | 1 |
1 review(s) available for tenofovir and adenosine monophosphate
| Article | Year |
|---|---|
Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
Topics: Adenine; Adenosine Monophosphate; Anti-HIV Agents; Biological Availability; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Viral Load | 2003 |
1 trial(s) available for tenofovir and adenosine monophosphate
| Article | Year |
|---|---|
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR).
Topics: Adenosine Monophosphate; Adult; Alanine; Anti-HIV Agents; Atazanavir Sulfate; Healthy Volunteers; Humans; Lamivudine; Oligopeptides; Pyridines; Ritonavir; Tenofovir; Uganda | 2021 |
4 other study(ies) available for tenofovir and adenosine monophosphate
| Article | Year |
|---|---|
Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates.
Topics: 2-Aminopurine; Adenosine Monophosphate; Amino Acid Sequence; Aminohydrolases; Biocatalysis; Cell Line, Tumor; Cloning, Molecular; Electrophoresis, Polyacrylamide Gel; Humans; Hydrolysis; Isoenzymes; Kinetics; Molecular Sequence Data; Molecular Structure; Molecular Weight; Nucleoside Deaminases; Phosphorylation; Purines; Recombinant Proteins; Sequence Analysis, Protein; Sequence Homology, Amino Acid; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Zinc | 2011 |
Synthesis of {[5-(adenin-9-yl)-2-furyl]methoxy}methyl phosphonic acid and evaluations against human adenylate kinases.
Topics: Adenine; Adenylate Kinase; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Organophosphonates; Structure-Activity Relationship | 2014 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Carboxylesterase; COVID-19 Drug Treatment; Drug Interactions; Enzyme Inhibitors; Humans; Microsomes; Pharmaceutical Preparations; Tenofovir | 2021 |